South America Pharmacy Benefit Management Services Market

ID: MRFR/Pharma/48956-HCR
200 Pages
Vikita Thakur
Last Updated: April 06, 2026
South America Pharmacy Benefit Management Services Market Research Report By Service Type (Claims Management, Formulary Management, Drug Utilization Review, Medication Therapy Management), By End User (Pharmacies, Health Plans, Employers, Public Sector), By Service Provider (Standalone Pharmacy Benefit Managers, Health Insurance Companies, Integrated Health Systems), By Operating Model (Fully-Managed Services, Pass-Through Services, Hybrid Services) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South America Pharmacy Benefit Management Services Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)6.14%
2024 Market Size$ 26.58 Billion
2025 Market Size$ 28.22 Billion
2035 Market Size$ 51.21 Billion

Key Players

CVS Health
Express Scripts
OptumRx
Humana
Cigna
Prime Therapeutics
Trends
  • Technological Integration
  • Regulatory Developments
  • Focus on Chronic Disease Management
Opportunities
  • Rising Healthcare Costs
  • Growing Focus on Preventive Care
  • Expansion of Health Insurance Coverage
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Service Type (USD Billion)
      1. 4.1.1 Claims Processing
      2. 4.1.2 Drug Utilization Review
      3. 4.1.3 Formulary Management
      4. 4.1.4 Clinical Management
    2. 4.2 Healthcare, BY Payer Type (USD Billion)
      1. 4.2.1 Health Insurance Companies
      2. 4.2.2 Self-Insured Employers
      3. 4.2.3 Government Programs
      4. 4.2.4 Pharmacy Benefit Managers
    3. 4.3 Healthcare, BY Client Type (USD Billion)
      1. 4.3.1 Large Employers
      2. 4.3.2 Small to Medium Enterprises
      3. 4.3.3 Healthcare Providers
      4. 4.3.4 Pharmacies
    4. 4.4 Healthcare, BY Plan Type (USD Billion)
      1. 4.4.1 Commercial Plans
      2. 4.4.2 Medicare Plans
      3. 4.4.3 Medicaid Plans
      4. 4.4.4 Employer-Sponsored Plans
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 UnitedHealth Group (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Cigna (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Anthem (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Aetna (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Grupo NotreDame Intermedica (BR)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Farmafuturo (AR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Medicoop (BR)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Grupo Sabra (BR)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 FarmaBrasil (BR)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY SERVICE TYPE
    3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY PAYER TYPE
    4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY CLIENT TYPE
    5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY PLAN TYPE
    6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF HEALTHCARE
    9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
    12. 6.12 HEALTHCARE, BY SERVICE TYPE, 2024 (% SHARE)
    13. 6.13 HEALTHCARE, BY SERVICE TYPE, 2024 TO 2035 (USD Billion)
    14. 6.14 HEALTHCARE, BY PAYER TYPE, 2024 (% SHARE)
    15. 6.15 HEALTHCARE, BY PAYER TYPE, 2024 TO 2035 (USD Billion)
    16. 6.16 HEALTHCARE, BY CLIENT TYPE, 2024 (% SHARE)
    17. 6.17 HEALTHCARE, BY CLIENT TYPE, 2024 TO 2035 (USD Billion)
    18. 6.18 HEALTHCARE, BY PLAN TYPE, 2024 (% SHARE)
    19. 6.19 HEALTHCARE, BY PLAN TYPE, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SERVICE TYPE, 2026-2035 (USD Billion)
      2. 7.2.2 BY PAYER TYPE, 2026-2035 (USD Billion)
      3. 7.2.3 BY CLIENT TYPE, 2026-2035 (USD Billion)
      4. 7.2.4 BY PLAN TYPE, 2026-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South America South America Pharmacy Benefit Management Services Market Segmentation

South America Pharmacy Benefit Management Services Market By Service Type (USD Billion, 2022-2035)

  • Claims Processing
  • Drug Utilization Review
  • Formulary Management
  • Clinical Management

South America Pharmacy Benefit Management Services Market By Payer Type (USD Billion, 2022-2035)

  • Health Insurance Companies
  • Self-Insured Employers
  • Government Programs
  • Pharmacy Benefit Managers

South America Pharmacy Benefit Management Services Market By Client Type (USD Billion, 2022-2035)

  • Large Employers
  • Small to Medium Enterprises
  • South America Pharmacy Benefit Management Services Market Providers
  • Pharmacies

South America Pharmacy Benefit Management Services Market By Plan Type (USD Billion, 2022-2035)

  • Commercial Plans
  • Medicare Plans
  • Medicaid Plans
  • Employer-Sponsored Plans

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035